Asset 1

Gentest® Myeloid and Erythroid Cell Maturation Assay Services

Assess neutropenia or severe anemia caused by drug candidate toxicity to neutrophils and red blood cells at various stages of cell development.

While myeloid and erythroid colony forming cell (CFC) assays are predictive of neutropenia and severe anemia caused by drugs impacting the primitive progenitor stage, toxicity can also occur at later stages of cell development.

Discovery’s myeloid and erythroid cell maturation assay services further assess the off-target toxicity potential of your drug candidate on developing neutrophils and red blood cells at different stages of cell development.

Contact Us Today

Quick Links

Technologies

Development and Clinical
Trial Solutions